MOUNTAIN VIEW, Calif., Feb. 15, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the most effective non-surgical permanent birth control method available, announced today that management is planning to present at two investor conferences in March 2011. The conferences and presentation dates and times are as follows:
- Raymond James 32nd Annual Institutional Investors Conference on Wednesday, March 9, 2011, at 8:05 a.m. Eastern time at the JW Marriott Orlando Grande Lakes, Orlando, FL
- Roth 23rd Annual OC Growth Stock Conference on Monday, March 14, 2011, at 12:00 p.m. Pacific time at The Ritz Carlton, Laguna Niguel, CA
Live webcasts of the presentations will be available on the company's website at www.conceptus.com . When accessing the webcasts through the Conceptus site, select "Investors" then select "Events and Presentations." The archived replay for the Raymond James 32nd Annual Institutional Investors Conference will be available for a period of 7 days. The archived replay for the Roth 23rd Annual OC Growth Stock Conference will be available for a period of 30 days.
About the Essure® ProcedureThe Essure procedure, FDA approved since 2002, is the first permanent birth control method that can be performed in the comfort of a physician's office in less than 10 minutes (average hysteroscopic time) without hormones, cutting, burning or the risks associated with general anesthesia or tubal ligation. Soft, flexible inserts are placed in a woman's fallopian tubes through the cervix without incisions. Over the next three months, the body forms a natural barrier around the micro-inserts to prevent sperm from reaching the egg. The Essure procedure is 99.95% effective based on one year of follow up with zero pregnancies reported in clinical trials, making it the most effective form of permanent birth control on the market. The procedure is covered by most insurance plans, and when it is performed in a doctor's office the cost to the patient may be as low as a simple co-pay.